These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia. Mao C; Zhou M; Uckun FM J Biol Chem; 2001 Nov; 276(44):41435-43. PubMed ID: 11527964 [TBL] [Abstract][Full Text] [Related]
3. Sex-linked agammaglobulinemia (Bruton's disease). A case report. Chung JL; Huang JL; Hung IJ Changgeng Yi Xue Za Zhi; 1992 Mar; 15(1):39-43. PubMed ID: 1581837 [TBL] [Abstract][Full Text] [Related]
4. The clinical spectrum of Bruton's agammaglobulinemia. Stewart DM; Lian L; Nelson DL Curr Allergy Asthma Rep; 2001 Nov; 1(6):558-65. PubMed ID: 11892085 [TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Sutherland LR; Martin F; Bailey RJ; Fedorak RN; Poleski M; Dallaire C; Rossman R; Saibil F; Lariviere L Gastroenterology; 1997 Apr; 112(4):1069-77. PubMed ID: 9097988 [TBL] [Abstract][Full Text] [Related]
6. Renal amyloidosis in a patient with X-linked agammaglobulinemia (Bruton's disease) and bronchiectasis. Gonzalo-Garijo MA; Sánchez-Vega S; Pérez-Calderón R; Pérez-Rangel I; Corrales-Vargas S; Fernández de Mera JJ; Robles R J Clin Immunol; 2014 Jan; 34(1):119-22. PubMed ID: 24292696 [TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis. Coward S; Kuenzig ME; Hazlewood G; Clement F; McBrien K; Holmes R; Panaccione R; Ghosh S; Seow CH; Rezaie A; Kaplan GG Inflamm Bowel Dis; 2017 Mar; 23(3):461-472. PubMed ID: 28146003 [TBL] [Abstract][Full Text] [Related]
8. Aminosalicylates for induction of remission or response in Crohn's disease. Lim WC; Hanauer S Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400 [TBL] [Abstract][Full Text] [Related]
9. Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group. Singleton JW; Hanauer SB; Gitnick GL; Peppercorn MA; Robinson MG; Wruble LD; Krawitt EL Gastroenterology; 1993 May; 104(5):1293-301. PubMed ID: 8482443 [TBL] [Abstract][Full Text] [Related]
10. Juvenile onset psoriatic arthritis in a patient with X-linked agammaglobulinemia (Bruton's disease). Palazzi C; D'Amico E; Cacciatore P; Pennese E; Petricca A; Olivieri I Scand J Rheumatol; 2003; 32(5):309-11. PubMed ID: 14690146 [TBL] [Abstract][Full Text] [Related]
11. Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial. Prantera C; Cottone M; Pallone F; Annese V; Franzè A; Cerutti R; Bianchi Porro G Gastroenterology; 1999 Mar; 116(3):521-6. PubMed ID: 10029609 [TBL] [Abstract][Full Text] [Related]
12. [Bruton's syndrome in an 8-year-old boy]. Słomka A Pneumonol Pol; 1990; 58(2-3):129-32. PubMed ID: 2352882 [TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis: Republished. Coward S; Kuenzig ME; Hazlewood G; Clement F; McBrien K; Holmes R; Panaccione R; Ghosh S; Seow CH; Rezaie A; Kaplan GG Inflamm Bowel Dis; 2017 May; 23(5):E26-E37. PubMed ID: 30052985 [TBL] [Abstract][Full Text] [Related]
14. Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group. Hanauer SB; Krawitt EL; Robinson M; Rick GG; Safdi MA Am J Gastroenterol; 1993 Sep; 88(9):1343-51. PubMed ID: 8362827 [TBL] [Abstract][Full Text] [Related]
15. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103 [TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454 [TBL] [Abstract][Full Text] [Related]
17. The lesson of agammaglobulinemia 40 years after Bruton's discovery. Burgio GR; Ugazio AG; Notarangelo LD; Duse M Ann Allergy; 1993 Oct; 71(4):408-15. PubMed ID: 8214806 [TBL] [Abstract][Full Text] [Related]
18. Potential application of gene therapy to X-linked agammaglobulinemia. Moreau T; Calmels B; Barlogis V; Michel G; Tonnelle C; Chabannon C Curr Gene Ther; 2007 Aug; 7(4):284-94. PubMed ID: 17969561 [TBL] [Abstract][Full Text] [Related]
19. Predominance of sterile immunoglobulin transcripts in a female phenotypically resembling Bruton's agammaglobulinemia. de la Morena M; Haire RN; Ohta Y; Nelson RP; Litman RT; Day NK; Good RA; Litman GW Eur J Immunol; 1995 Mar; 25(3):809-15. PubMed ID: 7705412 [TBL] [Abstract][Full Text] [Related]
20. [Primary immunodeficiencies and Bruton's disease genetic analysis: which prospects offers this genetic diagnosis?]. d'Audigier C; Rodriguez C; Bertrand V Ann Biol Clin (Paris); 2006; 64(5):421-8. PubMed ID: 17040872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]